PBM, CVS Health and Ed DeVaney
CVS taps Ed DeVaney to lead its Caremark PBM
CVS Health has named Ed DeVaney as president of its pharmacy benefit manager, CVS Caremark. | DeVaney has served as interim president of Caremark since December 2024. The president's role was vacated when David Joyner took over as CEO of CVS Health in October.
CVS Pharmacy, Danvers
Despite a recent 45% rally, I maintain a 'Sell' view on CVS due to its underwhelming execution record and rising leverage ...
CVS Health (NYSE:CVS – Free Report) had its price target lifted by JPMorgan Chase & Co. from $80.00 to $81.00 in a report ...
Argus raised the firm’s price target on CVS Health (CVS) to $77 from $68 and keeps a Buy rating on the shares. Despite an uneven performance ...
Hosted on MSN14h
Grand Rapids CVS store closingAn earlier version of this story said that a CVS spokesperson told MLive that the closing date had changed from March 6 to ...
Some analysts are more optimistic about CVS’ ability to navigate higher-than-expected medical costs in its insurance unit ...
In a report released on February 14, Steven Silver from Argus Research maintained a Buy rating on CVS Health (CVS – Research Report). The ...
CVS announced the closure of 270 of its locations in 2025 as part of a plan to reduce store density and better serve customer ...
CVS is trying to turn around its drugstore chain and insurance business. The company spent a smaller percentage of premium ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback